AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 15,252
+92 (0.61%)
Feb 17, 2026, 9:24 AM GMT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 235.12 billion as of February 17, 2026. Its market cap has increased by 37.48% in one year.
Market Cap
235.12B
Enterprise Value
252.97B
Revenue
43.64B
Ranking
n/a
PE Ratio
31.20
Stock Price
15,252.36
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 235.12B, an increase of 5,067.09%. That is a compound annual growth rate of 12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 234.47B | 9.65% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 86.88B |
| Haleon | 36.45B |
| Smith & Nephew | 11.26B |
| Convatec Group | 4.44B |
| Hikma Pharmaceuticals | 3.49B |
| Genus | 2.03B |
| HUTCHMED (China) | 1.85B |
| Oxford Nanopore Technologies | 1.31B |